Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,641Revenue (TTM) $M849Net Margin (%)1.6Altman Z-Score0.8
Enterprise Value $M3,395EPS (TTM) $0.1Operating Margin %2.8Piotroski F-Score5
P/E(ttm)183Beneish M-Score-1.4Pre-tax Margin (%)-19.1Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %--Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow8.6y-y EBITDA Growth Rate %199ROA % (ttm)0.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)1.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M160ROIC % (ttm)-5.9Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2016-03-31 Reduce-0.24%$14.02 - $21.67
($17.57)
$ 16.47-6%Reduce -49.21%1,053,933
HZNPJulian Robertson 2016-03-31 Add0.19%$14.02 - $21.67
($17.57)
$ 16.47-6%Add 5.45%868,477
HZNPSteve Mandel 2016-03-31 Reduce-0.15%$14.02 - $21.67
($17.57)
$ 16.47-6%Reduce -10.28%13,997,232
HZNPKen Heebner 2016-03-31 Add0.09%$14.02 - $21.67
($17.57)
$ 16.47-6%Add 60.98%330,000
HZNPJulian Robertson 2015-12-31 Buy 2.3%$13.12 - $22.58
($19.53)
$ 16.47-16%New holding823,577
HZNPJoel Greenblatt 2015-12-31 Buy 0.49%$13.12 - $22.58
($19.53)
$ 16.47-16%New holding2,075,017
HZNPKen Heebner 2015-12-31 Buy 0.15%$13.12 - $22.58
($19.53)
$ 16.47-16%New holding205,000
HZNPRon Baron 2015-12-31 Sold Out $13.12 - $22.58
($19.53)
$ 16.47-16%Sold Out0
HZNPSteve Mandel 2015-09-30 Add1.03%$16.81 - $38.45
($31.59)
$ 16.47-48%Add 386.77%15,600,988
HZNPRon Baron 2015-09-30 Buy $16.81 - $38.45
($31.59)
$ 16.47-48%New holding31,999
HZNPSteve Mandel 2015-06-30 Buy 0.42%$25.6 - $34.74
($30.45)
$ 16.47-46%New holding3,204,972
HZNPJoel Greenblatt 2015-03-31 Sold Out -0.011%$12.8 - $25.97
($18.33)
$ 16.47-10%Sold Out0
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 16.4732%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 16.4743%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 16.4716%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nohria VirinderDirector 2016-06-15Sell25,000$17.69-6.9view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2016-02-26Sell4,100$20-17.65view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-12-10Sell4,456$20-17.65view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-09-21Sell7,750$31.78-48.17view
Watkins ThomasDirector 2015-08-19Buy10,000$31.32-47.41view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-07-15Sell26,887$35.55-53.67view
Himawan JeffDirector 2015-03-13Sell554,564$22.44-26.6view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.85-24.62view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.0536.68view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.0536.68view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Julian Robertson Buys 8 New Stakes in 4th Quarter Mar 09 2016 
Sheets Smith Wealth Management Buys Companies With no Debts Sep 01 2015 
Horizon Pharma Leads Stock Returns in Health Care Industry Aug 24 2015 
Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
Biotech Effectiveness: Horizon Pharma, Zafgen, XOMA Corp Mar 09 2015 

More From Other Websites
The Truth behind Horizon’s EV-to-EBITDA Performance Jun 30 2016
How Is Horizon Pharma Looking on a Price-to-Sales Basis? Jun 30 2016
Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing Jun 30 2016
Horizon Pharma (HZNP) Stock Closed Up as BMO Initiates Coverage Jun 29 2016
Clinigen Group - New MA program with Horizon Pharma Jun 29 2016
Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol... Jun 29 2016
Clinigen and Horizon Pharma enter partnership to initiate European Managed Access program for... Jun 29 2016
Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol... Jun 29 2016
7:00 am Horizon Pharma submits a sNDA w/ the FDA for RAVICTI Oral Liquid to expand the age range for... Jun 29 2016
Here’s Why Traders Are Watching These Stocks Today Jun 28 2016
Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : June 28, 2016 Jun 28 2016
June 28 Premarket Briefing: 10 Things You Should Know Jun 28 2016
Exclusive: Horizon Pharma explores potential stake sale - sources Jun 27 2016
Exclusive: Horizon Pharma explores potential stake sale - sources Jun 27 2016
Horizon Pharma plc Added to Russell 2000(R) and 3000(R) Indexes Jun 27 2016
Horizon Pharma plc Added to Russell 2000(R) and 3000(R) Indexes Jun 27 2016
Tweets on the Street: Pimco's Eurozone Concerns, Shkreli on Horizon Pharma Jun 10 2016
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting Jun 07 2016
Jazz Pharma Started At Buy; Visa And Wal-Mart Upgraded Jun 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)